XCUR
XCUR
NASDAQ · Biotechnology

Exicure Inc

$1.03
-0.03 (-2.83%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +2,892.2% upside
Low Target $21.30
Average Target $30.82
High Target $34.43
Current Price $1.03
Current
$1.03
Target
$30.82
$21.30 $30.82 avg $34.43
Scenario Analysis
Bear Case
$21.30
1,968.0%
Low target
Base Case
$30.82
+2,892.2%
Avg target
Bull Case
$34.43
+3,242.7%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$9.48
-89.1% from high
52-Week Low
$0.88
+17.7% from low
Target vs 52W High
$30.82
+225.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%